{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T05:21:31Z","timestamp":1793683291015,"version":"4.5.1"},"reference-count":47,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T00:00:00Z","timestamp":1618012800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,11,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Biological sex and gender have been reported to affect incidence and overall survival (OS) of curatively treated gastroesophageal cancer. The aim of this study was to compare palliative treatment allocation and OS between women and men with advanced gastroesophageal cancer.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Patients with an unresectable or metastatic esophageal (including cardia) adenocarcinoma (EAC) or squamous cell carcinoma (ESCC) or gastric adenocarcinoma (GAC) diagnosed in 2015-2018 were identified in the Netherlands Cancer Registry. Treatment allocation was compared using \u03c72 tests and multivariable logistic regression analyses, and OS using the Kaplan-Meier method with log-rank test and Cox proportional hazards analysis. All statistical tests were 2-sided.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Of patients with EAC (n\u2009=\u20093077), ESCC (n\u2009=\u2009794), and GAC (n\u2009=\u20091836), 18.0%, 39.4%, and 39.1% were women, respectively. Women less often received systemic treatment compared with men for EAC (42.7% vs 47.4%, P\u2009=\u2009.045) and GAC (33.8% vs 38.8%, P\u2009=\u2009.03) but not for ESCC (33.2% vs 39.5%, P\u2009=\u2009.07). Women had a lower probability of receiving systemic treatment for GAC in multivariable analyses (odds ratio [OR] = 0.79, 95% confidence interval [CI] = 0.62 to 1.00) but not for EAC (OR = 0.86, 95% CI = 0.69 to 1.06) and ESCC (OR = 0.81, 95% CI = 0.57 to 1.14). Median OS was lower in women with EAC (4.4 vs 5.2\u2009months, P\u2009=\u2009.04) but did not differ after adjustment for patient and tumor characteristics and systemic treatment administration.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>We observed statistically significant and clinically relevant gender differences in systemic treatment administration and OS in advanced gastroesophageal cancer. Causes of these disparities may be sex based (ie, related to tumor biology) as well as gender based (eg, related to differences in treatment choices).<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jnci\/djab075","type":"journal-article","created":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T21:41:01Z","timestamp":1617918061000},"page":"1551-1560","source":"Crossref","is-referenced-by-count":50,"title":["Gender Differences in Treatment Allocation and Survival of Advanced Gastroesophageal Cancer: A Population-Based Study"],"prefix":"10.1093","volume":"113","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3516-6743","authenticated-orcid":false,"given":"Willemieke P M","family":"Dijksterhuis","sequence":"first","affiliation":[{"name":"Amsterdam UMC, University of Amsterdam, Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam, the Netherlands"},{"name":"Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4821-2806","authenticated-orcid":false,"given":"Marianne C","family":"Kalff","sequence":"additional","affiliation":[{"name":"Amsterdam UMC, University of Amsterdam, Department of Surgery, Cancer Center Amsterdam, Amsterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4728-7013","authenticated-orcid":false,"given":"Anna D","family":"Wagner","sequence":"additional","affiliation":[{"name":"Department of Oncology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9678-1611","authenticated-orcid":false,"given":"Rob H A","family":"Verhoeven","sequence":"additional","affiliation":[{"name":"Amsterdam UMC, University of Amsterdam, Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam, the Netherlands"},{"name":"Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valery E P P","family":"Lemmens","sequence":"additional","affiliation":[{"name":"Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, the Netherlands"},{"name":"Department of Public Health, Erasmus MC, Erasmus University, Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martijn G H","family":"van Oijen","sequence":"additional","affiliation":[{"name":"Amsterdam UMC, University of Amsterdam, Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam, the Netherlands"},{"name":"Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9655-7601","authenticated-orcid":false,"given":"Suzanne S","family":"Gisbertz","sequence":"additional","affiliation":[{"name":"Amsterdam UMC, University of Amsterdam, Department of Surgery, Cancer Center Amsterdam, Amsterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8689-3134","authenticated-orcid":false,"given":"Mark I","family":"van Berge Henegouwen","sequence":"additional","affiliation":[{"name":"Amsterdam UMC, University of Amsterdam, Department of Surgery, Cancer Center Amsterdam, Amsterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3546-9709","authenticated-orcid":false,"given":"Hanneke W M","family":"van Laarhoven","sequence":"additional","affiliation":[{"name":"Amsterdam UMC, University of Amsterdam, Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,4,10]]},"reference":[{"key":"2021110218561236000_djab075-B1"},{"key":"2021110218561236000_djab075-B2","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.ejca.2018.07.005","article-title":"Cancer incidence and mortality patterns in Europe: estimates for 40 countries and 25 major cancers in 2018","volume":"103","author":"Ferlay","year":"2018","journal-title":"Eur J Cancer"},{"issue":"1","key":"2021110218561236000_djab075-B3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21590","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"2021110218561236000_djab075-B4","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/j.juro.2012.11.153","article-title":"Sex disparities in cancer mortality: the risks of being a man in the United States","volume":"189","author":"Najari","year":"2013","journal-title":"J Urol"},{"issue":"26","key":"2021110218561236000_djab075-B5","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1200\/JCO.2018.78.3290","article-title":"Sex differences in efficacy and toxicity of systemic treatments: an undervalued issue in the era of precision oncology","volume":"36","author":"\u00d6zdemir","year":"2018","journal-title":"J Clin Oncol"},{"issue":"10250","key":"2021110218561236000_djab075-B6","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(20)31561-0","article-title":"Sex and gender: modifiers of health, disease, and medicine","volume":"396","author":"Mauvais-Jarvis","year":"2020","journal-title":"Lancet"},{"issue":"13","key":"2021110218561236000_djab075-B7","doi-asserted-by":"crossref","first-page":"4344","DOI":"10.1245\/s10434-016-5448-0","article-title":"Sex disparity in gastric cancer: female sex is a poor prognostic factor for advanced gastric cancer","volume":"23","author":"Kim","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"2021110218561236000_djab075-B8","first-page":"77","article-title":"Survival of metastatic gastric cancer: significance of age, sex and race\/ethnicity","volume":"2","author":"Yang","year":"2011","journal-title":"J Gastrointest Oncol"},{"issue":"18","key":"2021110218561236000_djab075-B9","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1200\/JCO.2011.38.8751","article-title":"Influence of sex on the survival of patients with esophageal cancer","volume":"30","author":"Bohanes","year":"2012","journal-title":"J Clin Oncol"},{"key":"2021110218561236000_djab075-B10","first-page":"1914","article-title":"Gender medicine and oncology: report and consensus of an ESMO workshop","volume":"30","author":"Wagner","year":"2019","journal-title":"Cancer-Related Cogn Impair"},{"issue":"1","key":"2021110218561236000_djab075-B11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1542-3565(04)00602-0","article-title":"Epidemiologic risk factors for Barrett\u2019s esophagus and associated adenocarcinoma","volume":"3","author":"Wong","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"2021110218561236000_djab075-B12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2307\/2137284","article-title":"Revisiting the behavioral model and access to medical care: does it matter?","volume":"36","author":"Anderson","year":"1995","journal-title":"J Health Soc Behav"},{"issue":"6","key":"2021110218561236000_djab075-B13","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1245\/s10434-010-0985-4","article-title":"The American Joint Committee on Cancer: The 7th Edition of the AJCC Cancer Staging Manual and the future of TNM","volume":"17","author":"Edge","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"2021110218561236000_djab075-B14","volume-title":"TNM Classification of Malignant Tumours","author":"Brierley","year":"2017"},{"key":"2021110218561236000_djab075-B15","year":"2016"},{"key":"2021110218561236000_djab075-B16","year":"2014"},{"issue":"2","key":"2021110218561236000_djab075-B17","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/SLA.0000000000002063","article-title":"Hospital of diagnosis influences the probability of receiving curative treatment for esophageal cancer","volume":"267","author":"Van Putten","year":"2018","journal-title":"Ann Surg"},{"issue":"3","key":"2021110218561236000_djab075-B18","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/bjs.10054","article-title":"Hospital of diagnosis and probability of having surgical treatment for resectable gastric cancer","volume":"103","author":"Van Putten","year":"2016","journal-title":"Br J Surg"},{"key":"2021110218561236000_djab075-B19","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ejca.2020.08.010","article-title":"Hospital volume and beyond first-line palliative systemic treatment in metastatic oesophagogastric adenocarcinoma: a population-based study","volume":"139","author":"Dijksterhuis","year":"2020","journal-title":"Eur J Cancer"},{"issue":"5","key":"2021110218561236000_djab075-B20","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrc.2016.30","article-title":"Sexual dimorphism in cancer","volume":"16","author":"Clocchiatti","year":"2016","journal-title":"Nat Rev Cancer"},{"issue":"7517","key":"2021110218561236000_djab075-B21","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nature13480","article-title":"Comprehensive molecular characterization of gastric adenocarcinoma","volume":"513","author":"Bass","year":"2014","journal-title":"Nature"},{"key":"2021110218561236000_djab075-B22","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ejca.2020.02.017","article-title":"A population-based study on intestinal and diffuse type adenocarcinoma of the oesophagus and stomach in the Netherlands between 1989 and 2015","volume":"130","author":"van der Kaaij","year":"2020","journal-title":"Eur J Cancer"},{"issue":"11","key":"2021110218561236000_djab075-B23","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1002\/ijc.25596","article-title":"Predictors and survival of synchronous peritoneal carcinomatosis of colorectal origin: a population-based study","volume":"128","author":"Lemmens","year":"2011","journal-title":"Int J Cancer"},{"issue":"101846","key":"2021110218561236000_djab075-B24","article-title":"The metastatic pattern of intestinal and diffuse type gastric carcinoma - a Dutch national cohort study","volume":"69","author":"Koemans","year":"2020","journal-title":"Cancer Epidemiol"},{"issue":"1","key":"2021110218561236000_djab075-B25","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1093\/jnci\/djy082","article-title":"Associations between prediagnostic concentrations of circulating sex steroid hormones and esophageal\/gastric cardia adenocarcinoma among men","volume":"111","author":"Petrick","year":"2019","journal-title":"J Natl Cancer Inst."},{"issue":"1","key":"2021110218561236000_djab075-B26","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/SLA.0000000000003202","article-title":"Unique considerations for females undergoing esophagectomy","volume":"272","author":"Nobel","year":"2020","journal-title":"Ann Surg."},{"issue":"1","key":"2021110218561236000_djab075-B27","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1093\/jnci\/djy082","article-title":"Associations between prediagnostic concentrations of circulating sex steroid hormones and esophageal\/gastric cardia adenocarcinoma among men","volume":"111","author":"Petrick","year":"2019","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"2021110218561236000_djab075-B28","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3748\/wjg.v18.i5.393","article-title":"Estrogen, male dominance and esophageal adenocarcinoma: is there a link?","volume":"18","author":"Yang","year":"2012","journal-title":"World J Gastroenterol"},{"issue":"16","key":"2021110218561236000_djab075-B29","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1016\/j.ejca.2008.07.031","article-title":"Oestrogen and the enigmatic male predominance of gastric cancer","volume":"44","author":"Chandanos","year":"2008","journal-title":"Eur J Cancer"},{"key":"2021110218561236000_djab075-B30","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ejca.2019.08.010","article-title":"Influence of sex on chemotherapy efficacy and toxicity in oesophagogastric cancer: a pooled analysis of four randomised trials","volume":"121","author":"Davidson","year":"2019","journal-title":"Eur J Cancer"},{"issue":"7","key":"2021110218561236000_djab075-B31","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1001\/jamaoncol.2018.1080","article-title":"Association of patient sex with chemotherapy-related toxic effects: a retrospective analysis of the PETACC-3 trial conducted by the EORTC gastrointestinal group","volume":"4","author":"Cristina","year":"2018","journal-title":"JAMA Oncol"},{"issue":"10","key":"2021110218561236000_djab075-B32","first-page":"1","article-title":"The efficacy and safety of first-line chemotherapy in advanced esophagogastric cancer: a network meta-analysis","volume":"108","author":"Veer","year":"2016","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"2021110218561236000_djab075-B33","first-page":"12","article-title":"Quality of life during palliative systemic therapy for esophagogastric cancer: systematic review and meta-analysis","volume":"112","author":"Van Kleef","year":"2020","journal-title":"J Natl Cancer Inst"},{"issue":"3-4","key":"2021110218561236000_djab075-B34","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1177\/0825859717738464","article-title":"The final 30 days of life: a study of patients with gastrointestinal cancer in Ontario, Canada","volume":"32","author":"Merchant","year":"2017","journal-title":"J Palliat Care"},{"issue":"2011","key":"2021110218561236000_djab075-B35","first-page":"1","article-title":"Re-revisiting Andersen\u2019s behavioral model of health services use: a systematic review of studies from 1998-2011","volume":"9","author":"Babitsch","year":"2012","journal-title":"GMS Psycho-Social-Med."},{"issue":"6","key":"2021110218561236000_djab075-B36","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1634\/theoncologist.2009-0337","article-title":"Gender-related needs and preferences in cancer care indicate the need for an individualized approach to cancer patients","volume":"15","author":"Wessels","year":"2010","journal-title":"Oncologist"},{"issue":"1","key":"2021110218561236000_djab075-B37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jpainsymman.2018.03.014","article-title":"Preference for palliative care in cancer patients: are men and women alike?","volume":"56","author":"Saeed","year":"2018","journal-title":"J Pain Symptom Manage"},{"key":"2021110218561236000_djab075-B38","year":"2019"},{"key":"2021110218561236000_djab075-B39","year":"2019"},{"issue":"6","key":"2021110218561236000_djab075-B40","first-page":"e498","article-title":"Association between marital status and racial disparities in esophageal cancer care","volume":"16","author":"Paniagua","year":"2020","journal-title":"J Clin Oncol Pract"},{"issue":"56","key":"2021110218561236000_djab075-B41","doi-asserted-by":"crossref","first-page":"95965","DOI":"10.18632\/oncotarget.21609","article-title":"Marital status is associated with superior survival in patients with esophageal cancer: a surveillance, epidemiology, and end results study","volume":"8","author":"Du","year":"2017","journal-title":"Oncotarget"},{"issue":"10","key":"2021110218561236000_djab075-B42","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1056\/NEJMms1902657","article-title":"Death by stereotype? Cancer treatment in unmarried patients","volume":"381","author":"DelFattore","year":"2019","journal-title":"N Engl J Med"},{"issue":"7","key":"2021110218561236000_djab075-B43","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1097\/ACM.0b013e318295b3fe","article-title":"Using patients\u2019 narratives to reveal gender stereotypes among medical students","volume":"88","author":"Andersson","year":"2013","journal-title":"Acad Med"},{"issue":"7","key":"2021110218561236000_djab075-B44","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1089\/152460902760360595","article-title":"Gender bias in physicians\u2019 management of neck pain: a study of the answers in a Swedish national examination","volume":"11","author":"Hamberg","year":"2002","journal-title":"J Womens Health Gend Based Med"},{"issue":"1","key":"2021110218561236000_djab075-B45","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12910-017-0179-8","article-title":"Implicit bias in healthcare professionals: a systematic review","volume":"18","author":"Fitzgerald","year":"2017","journal-title":"BMC Med Ethics"},{"issue":"3","key":"2021110218561236000_djab075-B46","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00520-010-0865-2","article-title":"Age and gender differences in symptom intensity and symptom clusters among patients with metastatic cancer","volume":"19","author":"Cheung","year":"2011","journal-title":"Support Care Cancer"},{"issue":"10","key":"2021110218561236000_djab075-B47","first-page":"1623","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"4","author":"Von","year":"2007","journal-title":"PLoS Med"}],"container-title":["JNCI: Journal of the National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jnci\/advance-article-pdf\/doi\/10.1093\/jnci\/djab075\/39070509\/djab075.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jnci\/article-pdf\/113\/11\/1551\/41054047\/djab075.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jnci\/article-pdf\/113\/11\/1551\/41054047\/djab075.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,2]],"date-time":"2021-11-02T21:40:30Z","timestamp":1635889230000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnci\/article\/113\/11\/1551\/6219955"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,10]]},"references-count":47,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2021,4,10]]},"published-print":{"date-parts":[[2021,11,2]]}},"URL":"https:\/\/doi.org\/10.1093\/jnci\/djab075","relation":{},"ISSN":["0027-8874","1460-2105"],"issn-type":[{"value":"0027-8874","type":"print"},{"value":"1460-2105","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,11,1]]},"published":{"date-parts":[[2021,4,10]]}}}